Clinical trial
Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress…
NCT00120250 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00120250 |
|---|---|
| Title | Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder |
| Official title | Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Post-Traumatic Stress Disorders |
| Intervention type | Drug |
| Interventions | Eszopiclone |
| Enrollment | 27 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jul 15, 2005 |
| Last update posted | Apr 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: